NovoSeven skulle have været anvendt til at behandle voksne patienter med intracerebral hæmorrhagi (blødning inde i hjernen).
Following review of the data submitted, the Committee for Medicinal Products for Human Use (CHMP) requested the company to submit additional safety and efficacy data.